BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34797586)

  • 21. A Case of Biphenotypic Adnexal Carcinoma With Bowenoid and Basaloid Features: Focus on the Expression of SOX9 and Wnt Signaling Pathway Molecules, Including CDX2.
    Sugimoto A; Fujimoto M; Masuo Y; Nakagawa Y; Yamada Y; Kono F; Haga H
    Am J Dermatopathol; 2023 Dec; 45(12):835-838. PubMed ID: 37883950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDX2 and LEF-1 expression in pilomatrical tumors and their utility in the diagnosis of pilomatrical carcinoma.
    Tumminello K; Hosler GA
    J Cutan Pathol; 2018 May; 45(5):318-324. PubMed ID: 29369390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.
    Zhang YJ; Chen JW; He XS; Zhang HZ; Ling YH; Wen JH; Deng WH; Li P; Yun JP; Xie D; Cai MY
    EBioMedicine; 2018 Feb; 28():62-69. PubMed ID: 29396302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases.
    Schmoeckel E; Kirchner T; Mayr D
    Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Giannico GA; Gown AM; Epstein JI; Revetta F; Bishop JA
    Hum Pathol; 2017 Sep; 67():152-159. PubMed ID: 28711650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.
    Ma C; Olevian DC; Lowenthal BM; Jayachandran P; Kozak MM; Chang DT; Pai RK
    Am J Surg Pathol; 2018 Oct; 42(10):1409-1417. PubMed ID: 30001238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilomatrix carcinoma arising from pilomatricoma after 10-year senescent period: Immunohistochemical analysis.
    Nishioka M; Tanemura A; Yamanaka T; Tani M; Miura H; Asakura M; Tamai N; Katayama I
    J Dermatol; 2010 Aug; 37(8):735-9. PubMed ID: 20649718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
    Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
    Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Neoadjuvant Chemotherapy on SATB2 Expression in Colorectal Carcinomas: SATB2 Positivity is Preserved in Most Cases, but Down-Expressed in Effective Cases of Chemotherapy.
    Asahina Y; Hashimoto H; Aihara M; Noie T; Morikawa T
    Int J Surg Pathol; 2023 Feb; 31(1):46-55. PubMed ID: 35343276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilomatrix carcinoma: 13 new cases and review of the literature with emphasis on predictors of metastasis.
    Herrmann JL; Allan A; Trapp KM; Morgan MB
    J Am Acad Dermatol; 2014 Jul; 71(1):38-43.e2. PubMed ID: 24739254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SATB2 is expressed in Merkel cell carcinoma.
    Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
    Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilomatrix carcinoma with lymph node metastases.
    Bassarova A; Nesland JM; Sedloev T; Danielsen H; Christova S
    J Cutan Pathol; 2004 Apr; 31(4):330-5. PubMed ID: 15005691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors.
    Li Z; Rock JB; Roth R; Lehman A; Marsh WL; Suarez A; Frankel WL
    Am J Clin Pathol; 2018 Feb; 149(3):241-246. PubMed ID: 29471325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical presentation of pilomatricoma: a case report.
    Sari A; Yavuzer R; Isik I; Latifoglu O; Ataoglu O
    Dermatol Surg; 2002 Jul; 28(7):603-5. PubMed ID: 12135516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous neuroendocrine carcinoma within a cystic trichoblastoma: a nonfortuitous association?
    Battistella M; Durand L; Jouary T; Peltre B; Cribier B
    Am J Dermatopathol; 2011 Jun; 33(4):383-7. PubMed ID: 21048490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine.
    Lin F; Shi J; Zhu S; Chen Z; Li A; Chen T; Wang HL; Liu H
    Arch Pathol Lab Med; 2014 Aug; 138(8):1015-26. PubMed ID: 24437456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.
    Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilomatricoma mimicking small round cell tumor on fine needle aspiration cytology: a case report.
    Thapliyal N; Joshi U; Vaibhav G; Sayana A; Srivastava AK; Jha RS
    Acta Cytol; 2008; 52(5):627-30. PubMed ID: 18833830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilomatrix carcinoma: case report and review of literature.
    Dutta R; Boadle R; Ng T
    Pathology; 2001 May; 33(2):248-51. PubMed ID: 11358065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.